Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2019 Mar 11;25(7):1424–1431. doi: 10.1016/j.bbmt.2019.03.001

Figure 2. Most outcomes did not differ between patients who received alternative AEMs compared to those who received phenytoin after conditioning with oral or IV BU followed by CY.

Figure 2.

Diamonds indicate the hazard ratio point estimates when results for the alternative AEM group were compared to those for the phenytoin group. Bars indicate the 95% confidence intervals. Each statistical model includes risk factor covariate adjustments derived from the entire cohort.